Not sure if your MS management plan is up-to-date? Take this quiz to find out. When living with a chronic, progressive disease like MS, it’s important that you’re aware of how your symptoms affect ...
Once multiple sclerosis (MS) is diagnosed (see presentation), periodic assessment of disease severity is important both for tracking disease progression (and establishing prognosis) and for monitoring ...
A previously "hidden" subtype of Multiple Sclerosis (MS)—a condition that affects the brain and spinal cord—has been uncovered. The distinct subtype exhibits "significant cognitive deficits with ...
Panelists discuss how patient-reported outcomes are crucial for capturing MS symptoms like fatigue, depression, and cognitive decline that significantly impact working-age patients but require ...
Multiple sclerosis (MS) is a complex disease with a wide range of clinical manifestations. Current disease-modifying drugs (DMDs) are effective, but they are associated with effects that may ...
New analysis will confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity' (NEDA4) in previously-treated highly-active RMS patients Separate analyses will show adding brain ...
Researchers have identified a new subtype of multiple sclerosis that affects thinking and memory rather than mobility — and as many as 26 percent of people with MS may have it. Researchers have ...
Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity. A study identified 12 significant radiomic features, with four ...
Hosted on MSN
Could You Have ‘Cognitive-Only’ MS and Not Know It?
Researchers have identified a MS subtype involving thinking and memory problems but no mobility impairment. Because routine MS screening and care focuses on mobility, these MS patients may not be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results